Hemodynamic Monitoring for Heart Failure Patients

Academic Content

Program Overview

Faculty Presentations

Introduction Akshay S. Desai MD, MPH William T. Abraham, MD

Faculty Roundtable Discussion

Presentation Notes and References

Current Activity

William T Abraham, MD, FACP, FACC, FAHA, FESC
Director, Division of Cardiovascular Medicine
Professor of Internal Medicine, Physiology and Cell Biology
The Ohio State University Wexner Medical Center
Deputy Director, Davis Heart and Lung Research Institute
The Ohio State University
Columbus, Ohio

Fig. 01 -

Presentation Title

Fig. 02 -

CHAMPION Trial Design

Fig. 03 -

PAP Measurement System

Fig. 04 -

CHAMPION PA Target Pressures

Fig. 05 -

Clinical outcomes

Fig. 06 -

PAP-M: Reduces hospitalizations

Fig. 07 -

PAP-M: Benefits and comorbidities

Fig. 08 -

PAP-M: Better than GDMT

Fig. 09 -

PAP-M: Lowers mortality

Fig. 10 -

CHAMPION lowers 30-day readmissions

Fig. 11 -

CHAMPION: Effect on CMS HRRP

Fig. 12 -

CHAMPION: Longitudinal analysis(1)

Fig. 13 -

CHAMPION: Longitudinal analysis(2)

Return to:

The American Journal of Cardiology

« Prev

Next »
Click Figure to Enlarge

Auto-play

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

The American Journal of Cardiology

Print This Page

Abraham - Figure 11

Comparison with CMS Hospital Readmissions Reduction Program (HRRP)

To look at the hospitalization data in a different way, we compared the CHAMPION results to the CMS hospital readmission reduction program (HRRP) index. This is the index that CMS uses to penalize hospitals for excess 30-day readmissions: an index >1 results in a penalty, whereas an index <1 results in no penalty.

Figure 11 shows hospital readmission data from all of the hospitals in the United States, shown by grey dots, with the same data from the CHAMPION study sites highlighted in green.^[11] It can be seen that in general about half of the gray dots fall above the index line for 1.00 and half fall below the line. But when the same 30-day readmission index for the PAP-treatment patients in the CHAMPION sites is calculated, the index was 0.74 – ie, lower than what has been produced by any hospital in the United States. Again, these are preliminary data and they do not tell the complete story, but these data suggest quite strongly that the use of PAP-guided management will also lower 30-day hospitalization readmission rates.

Abraham WT. Am J Cardiol. 2015; 00.

References

[11]

Adamson PB, Abraham WT, Bauman J, Yadav J. Impact of wireless pulmonary artery pressure monitoring on heart failure hospitalizations and all-cause 30-day readmissions in Medicare-eligible patients with NYHA Class III heart failure: Results from the CHAMPION trial. Circulation. 2014;130:A16744.

« Prev